Orforglipron 30 x 3mg tabs
Orforglipron 30 x 3mg tabs
$120.00 Add to cart

Orforglipron 30 x 3mg tabs

$120.00

Orforglipron (30 x 3mg tabs) is the world’s first oral small-molecule GLP-1 receptor agonist — a major breakthrough that delivers the metabolic power of GLP-1 therapy in a simple daily tablet. No injections. No fasting. No food restrictions. Just measurable weight reduction, sharper appetite control, and improved metabolic markers.

In stock

Title Range Discount
Bulk Discount OptimaSciences 3 - 4 10%
Bulk Discount OptimaSciences 5 + 15%
Dispatch2 business days
CarrierCanada Post, tracked
Free shippingOrders over $200
Storage−20 °C, our freezer

⚠️ Research Use Only (RUO). Not for human or veterinary use.

Orforglipron is a non-peptide small molecule GLP-1 receptor agonist, formula C48H48F2N10O5, 882.97 g/mol. Being a small molecule rather than a peptide is exactly why it survives the stomach and can be taken as a tablet at all, and its two fluorine atoms are a standard approach to slowing metabolic breakdown.

Supplied as 30 oral tablets of 3 mg each, release specification ≥99% by HPLC. Verified and packed in our Ontario lab. No reconstitution and no bacteriostatic water required. The certificate for your batch is in the photos above.

We do not import Orforglipron 30 x 3mg tabs finished. We buy the raw material and do the purification, verification and pressing ourselves, in Ontario.

Additional information

Weight 0.1 kg
Dimensions 15 × 15 × 2 cm

Customer Reviews

Real feedback from customers who purchased this product.

No reviews yet. Be the first!

Why choose Orforglipron

What it is chosen for.

✓

Oral convenience. Phase 3 trials show weight reduction comparable to leading injectable GLP-1 therapies, without the needles or refrigeration.

✓

Powerful appetite control. Modulates hunger signals and cravings, making calorie control feel effortless.

✓

Metabolic reset. Supports healthier blood sugar, lower waist circumference and improved cardiometabolic markers.

✓

Premium quality. Sourced from trusted suppliers, sealed and purity tested for maximum safety.

The compound

Orforglipron, in short.

Not a peptide at all

The only GLP-1 receptor agonist here that is a small molecule. That is precisely why it survives the stomach and can be taken as a tablet.

Two fluorine atoms

Formula C48H48F2N10O5. Fluorine is a favourite trick of medicinal chemists for slowing metabolic breakdown.

Solved in 2020

Kawai and colleagues published the receptor structure in PNAS, under the code LY3502970.

Finished in Ontario, Canada

Verified and packed in our own lab. Full numbers below.

Specification

What is in the tablet, down to the formula.

The molecule

ClassNon-peptide small molecule GLP-1 receptor agonist
LengthNot a peptide
CAS number2212020-52-3
FormulaC48H48F2N10O5
Molecular weight882.97 g/mol
OriginFully synthetic
First describedPNAS, 2020

This product

Fill weight3 mg
FormOral tablet
Purity≥99% by HPLC · release spec
IdentityConfirmed by mass spectrometry
Storage−20 °C, protected from light
ManufacturedOntario, Canada